Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 202

1.

Dynamic analysis of the interactions between Si/SiO2 quantum dots and biomolecules for improving applications based on nano-bio interfaces.

Stan MS, Cinteza LO, Petrescu L, Mernea MA, Calborean O, Mihailescu DF, Sima C, Dinischiotu A.

Sci Rep. 2018 Mar 27;8(1):5289. doi: 10.1038/s41598-018-23621-x.

2.

Myocardial Infarction Injury in Patients with Chronic Lung Disease Entering Pulmonary Rehabilitation: Frequency and Association with Heart Rate Parameters.

Sima CA, Lau BC, Taylor CM, van Eeden SF, Reid WD, Sheel AW, Kirkham AR, Camp PG.

PM R. 2018 Mar 14. pii: S1934-1482(18)30124-2. doi: 10.1016/j.pmrj.2018.03.005. [Epub ahead of print]

PMID:
29550408
3.

Author Correction: ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance.

Sima C, Montero E, Nguyen D, Freire M, Norris P, Serhan CN, Van Dyke TE.

Sci Rep. 2018 Mar 2;8(1):4143. doi: 10.1038/s41598-018-22520-5.

4.

Vismodegib Use in Clinical Practice: Analysis of a United States Medical Claims Database.

Hanke CW, Mhatre SK, Oliveri D, Zivkovic M, Caro I, Bergström D, Dawson K, Sima CS.

J Drugs Dermatol. 2018 Feb 1;17(2):143-148.

PMID:
29462221
5.

Integrated reconfigurable photonic filters based on interferometric fractional Hilbert transforms.

Sima C, Cai B, Liu B, Gao Y, Yu Y, Gates JC, Zervas MN, Smith PGR, Liu D.

Appl Opt. 2017 Oct 1;56(28):7978-7984. doi: 10.1364/AO.56.007978.

PMID:
29047786
6.

ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance.

Sima C, Montero E, Nguyen D, Freire M, Norris P, Serhan CN, Van Dyke TE.

Sci Rep. 2017 Oct 9;7(1):12848. doi: 10.1038/s41598-017-13185-7. Erratum in: Sci Rep. 2018 Mar 2;8(1):4143.

7.

Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib.

Bhutani T, Abrouk M, Sima CS, Sadetsky N, Hou J, Caro I, Chren MM, Arron ST.

J Am Acad Dermatol. 2017 Oct;77(4):713-718. doi: 10.1016/j.jaad.2017.03.038. Epub 2017 Aug 2.

PMID:
28780365
8.

The reliability of short-term measurement of heart rate variability during spontaneous breathing in people with chronic obstructive pulmonary disease.

Sima CA, Inskip JA, Sheel AW, van Eeden SF, Reid WD, Camp PG.

Rev Port Pneumol (2006). 2017 Nov - Dec;23(6):338-342. doi: 10.1016/j.rppnen.2017.06.001. Epub 2017 Jul 8.

9.

Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.

Sherman EJ, Dunn LA, Ho AL, Baxi SS, Ghossein RA, Fury MG, Haque S, Sima CS, Cullen G, Fagin JA, Pfister DG.

Cancer. 2017 Nov 1;123(21):4114-4121. doi: 10.1002/cncr.30861. Epub 2017 Jun 29.

PMID:
28662274
10.

Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers.

Yu HA, Sima C, Feldman D, Liu LL, Vaitheesvaran B, Cross J, Rudin CM, Kris MG, Pao W, Michor F, Riely GJ.

Ann Oncol. 2017 Feb 1;28(2):278-284. doi: 10.1093/annonc/mdw556.

11.

Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy.

Yang HX, Woo KM, Sima CS, Bains MS, Adusumilli PS, Huang J, Finley DJ, Rizk NP, Rusch VW, Jones DR, Park BJ.

Ann Surg. 2017 Feb;265(2):431-437. doi: 10.1097/SLA.0000000000001708.

12.

Temperature-insensitive fiber twist sensor based on elliptical-core few-mode fiber.

Yu D, Mo Q, Hong Z, Fu S, Sima C, Tang M, Liu D.

Opt Lett. 2016 Oct 15;41(20):4617-4620. doi: 10.1364/OL.41.004617.

PMID:
28005850
13.

KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.

Kadota K, Sima CS, Arcila ME, Hedvat C, Kris MG, Jones DR, Adusumilli PS, Travis WD.

Am J Surg Pathol. 2016 Dec;40(12):1579-1590.

14.

Attaining Proficiency in Robotic-Assisted Minimally Invasive Esophagectomy While Maximizing Safety During Procedure Development.

Sarkaria IS, Rizk NP, Grosser R, Goldman D, Finley DJ, Ghanie A, Sima CS, Bains MS, Adusumilli PS, Rusch VW, Jones DR.

Innovations (Phila). 2016 Jul-Aug;11(4):268-73. doi: 10.1097/IMI.0000000000000297.

15.

A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.

Ho AL, Dunn L, Sherman EJ, Fury MG, Baxi SS, Chandramohan R, Dogan S, Morris LG, Cullen GD, Haque S, Sima CS, Ni A, Antonescu CR, Katabi N, Pfister DG.

Ann Oncol. 2016 Oct;27(10):1902-8. doi: 10.1093/annonc/mdw287. Epub 2016 Aug 26.

16.

A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer.

Pietanza MC, Litvak AM, Varghese AM, Krug LM, Fleisher M, Teitcher JB, Holodny AI, Sima CS, Woo KM, Ng KK, Won HH, Berger MF, Kris MG, Rudin CM.

Lung Cancer. 2016 Sep;99:23-30. doi: 10.1016/j.lungcan.2016.04.014. Epub 2016 Apr 26.

17.

Physician-Driven Variation in Nonrecommended Services Among Older Adults Diagnosed With Cancer.

Lipitz-Snyderman A, Sima CS, Atoria CL, Elkin EB, Anderson C, Blinder V, Tsai CJ, Panageas KS, Bach PB.

JAMA Intern Med. 2016 Oct 1;176(10):1541-1548. doi: 10.1001/jamainternmed.2016.4426.

18.

Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance.

Revelo XS, Ghazarian M, Chng MH, Luck H, Kim JH, Zeng K, Shi SY, Tsai S, Lei H, Kenkel J, Liu CL, Tangsombatvisit S, Tsui H, Sima C, Xiao C, Shen L, Li X, Jin T, Lewis GF, Woo M, Utz PJ, Glogauer M, Engleman E, Winer S, Winer DA.

Cell Rep. 2016 Jul 19;16(3):717-30. doi: 10.1016/j.celrep.2016.06.024. Epub 2016 Jun 30.

19.

Distinct Oral Neutrophil Subsets Define Health and Periodontal Disease States.

Fine N, Hassanpour S, Borenstein A, Sima C, Oveisi M, Scholey J, Cherney D, Glogauer M.

J Dent Res. 2016 Jul;95(8):931-8. doi: 10.1177/0022034516645564. Epub 2016 Jun 6.

PMID:
27270666
20.

Supplemental Content

Support Center